RBC Life Sciences, Inc. (RBCL)

[Helter Skelter]

Market cap of $8.6M, revenues on pace for $32M and...PROFITABLE! EPS on pace for $.04-$.05. With a PE ratio of 20 the price per share would be $.80-$1.00...AND...the company is enjoying significant growth {16% Q over Q} in this Great Recession. A 1:1 Price/Sales ratio would equate to a price per share of $1.45, almost a 4 bagger from here {$.39}. Can you picture a Price/Sales ratio of 2? Or 3?

OS is 22M. Float 7.5M. CEO owns 44% of the OS.

Can you say...UNDERVALUED? I can. Just waiting for this gem to be "discovered"...and the ensuing liquidity.

Good day.

Take a quick peek at last Q's balance sheet. Note current assets vs current liabilities and total assets vs total liabilities: